Against my better instincts - which made me decide a few months ago not to bother posting any more on this board - I will make a few comments.
First of all, Zeppo, I don't always agree with your conclusions - although often I do - but I do appreciate very much the intelligent, knowledgeable, and thoughtful way in which you express yourself, and the constructive tone of your criticisms.
From what I have gathered from my contacts, the goal of the South American agreement was gaining financial security for the interim, until sales will provide a consistent revenue stream. This is confidently anticipated to happen well within the year and a half that this money will provide.
Apparently, the investors, whoever they are, shared that confidence, and put down a cool million at full market price, with a possible second million in a few months, with a lock on selling their shares for a year. They must feel pretty comfortable that something is brewing in the next year or so.
Again, based on what I've picked up from other shareholders who are well-connected, the main use of this money will be to fund the 2nd-generation machines that have already been developed and tested, and are much more powerful than the original AS unit. Medizone will then be ready to produce machines when larger orders begin to come in.
True, the potential sales in Canada and KSA are dragging on much longer than was expected, but there still seems to be positive movement on both fronts.
What has been frustrating to all of us is the length of time that EPA approval has taken, but that is just beyond anyone's control, as confirmed by the lobbyist in DC. The people I've spoken with seem hopeful that there are no outstanding issues, but it ain't over till it's over.
All JMO, of course.
AI
